Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up
Recruiting · NCT04688593 · Observational (researchers observe without assigning treatment) · Lead sponsor: Waldemar Link GmbH & Co. KG
View the official record on ClinicalTrials.gov →Interventions studied
MobileLink
What this trial is about
The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results. The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link
- Age ≥ 18 years
- Fully signed patient informed cons
Exclusion criteria
- Revisions
- Body Mass Index (BMI) ≥ 40 kg/m²
- Patient who is foreseeable not able to understand the study and the study-related circumstances
- Patients who is foreseeable non-compliant to the treatment and the follow-ups
- Pregnant or breast-feeding women
- Prisoner
Where it is running
2 locations listed.
- Lubinus Stiftung - Kiel, Germany
- NHS FIFE Victoria Hospital - Kirkcaldy, United Kingdom